W
AZN icon

WealthCollab’s AstraZeneca AZN Stock Holding History

WealthCollab’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Sell
82
-6
-7% -$1.13K 0.01% 472
2026
Q1 		$17.4K Sell
88
-2
-2% -$386 0.01% 405
2025
Q4 		$16.5K Hold
90
– – 0.01% 439
2025
Q3 		$13.7K Hold
90
– – 0.01% 443
2025
Q2 		$12.5K Hold
90
– – 0.01% 443
2025
Q1 		$13.2K Buy
90
+5
+6% +$723 0.01% 402
2024
Q4 		$11.1K Buy
85
+78
+1,114% +$10.9K 0.01% 420
2024
Q3 		$1.01K Hold
7
– – ﹤0.01% 833
2024
Q2 		$1.01K Hold
7
– – ﹤0.01% 809
2024
Q1 		$881 Sell
7
-3
-30% -$397 ﹤0.01% 825
2023
Q4 		$1.28K Buy
+10
New +$1.3K ﹤0.01% 797

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WealthCollab's AZN Position: Q2 2026 in Review

WealthCollab reduced its AstraZeneca (AZN) stake by 6.8% in Q2 2026, selling an estimated $1.13K and leaving 82 shares worth $15.5K. The position accounts for 0.01% of the portfolio, ranked #472.

WealthCollab first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $17.4K in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • WealthCollab held 82 shares of AstraZeneca worth $15.5K as of Q2 2026.
  • WealthCollab sold 6 AstraZeneca shares in Q2 2026, an estimated $1.13K.
  • AstraZeneca made up 0.01% of WealthCollab's portfolio in Q2 2026, its #472 holding.
  • WealthCollab first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's AstraZeneca position peaked at $17.4K in Q1 2026.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.